Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up.
Benner
S E
SE
Department of Thoracic/Head and Neck Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
Pajak
T F
TF
Lippman
S M
SM
Earley
C
C
Hong
W K
WK
D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D004067:Digestive System Neoplasms / Q000517:prevention & control; D004311:Double-Blind Method; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms / Q000188:drug therapy*; D006801:Humans; D015474:Isotretinoin / Q000627:therapeutic use*; D016609:Neoplasms, Second Primary / Q000517:prevention & control*; D012142:Respiratory Tract Neoplasms / Q000517:prevention & control; D016019:Survival Analysis
D015474:Isotretinoin